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Abstract 
The SLC6A4 gene encodes a sodium-dependent 
serotonin reuptake protein delivering the 
neurotransmitter serotonin from the synaptic cleft 
back to the presynaptic end. Its main function is to 
abort the activity of serotonin and forward it to 
neurotransmitter pool for recycling. The 
psychomotor stimulant drugs mainly amphetamines 
and cocaine act on this transmembrane protein which 
is a member of the sodium: neurotransmitter 
symporter family. SLC6A4 gene polymorphisms 
affect the rate of serotonin reuptake and play an 
important role in pathogenesis of various illnesses 
like Sudden infant death syndrome, aggressive  
behaviour in Alzheimer patients, Seasonal affective 
disorder, Major depressive Disorder and Obsessive-
compulsive disorder. 
Keywords 
Solute Carrier Family 6 Member 4 (SLC6A4), 
Serotonin (5-HT), Serotonin transporter protein (5-
HTT), Anxiety, Alcoholism, Hypertension, Mental 
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Identity 
Other names: 5-HTT, 5-HTTLPR, 5HTT, HTT, 
OCD1, SERT, SERT1, hSERT 
HGNC (Hugo): SLC6A4 
Location: 17q11.2 
Figure 1. Genomic location of SLC6A4  (Chromosome 17 - NC_000017.11 Reference GRCh38.p12 Primary Assembly) 
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Figure 2. Chromosomal Location of SLC6A4.  Cytogenetic Location: 17q11.2, which is the long (q) arm of chromosome 17 at 
position 11.2 (U.S. National Library of Medicine) 
 
 
Figure 3. Numbers and illustrative sizes of exons of human SLC6A4.  (https:\\www.atlasgeneticsoncology.org) 
 
DNA/RNA 
The SLC6A4 gene is 41,684 bp long (according to 
UCSC, GRCh38/hg38), located on the plus strand 
and spans 15 exons (NCBI Homo sapiens 
Annotation Release 109). 
Transcription 
The gene has 5 transcripts (Table 1)  
Name Transcript ID bp 
Protein 
(aa)     
Biotype 
SLC6A4-
201   
ENST00000261707.7   6604   630 aa 
Protein 
coding 
SLC6A4-
202   
ENST00000394821.2   2160   618 aa 
Protein 
coding 
SLC6A4-
203   
ENST00000401766.6   6543   630 aa 
Protein 
coding 
SLC6A4-
204   
ENST00000578609.1   566   
No 
protein 
Retained 
intron 
SLC6A4-
205   
ENST00000579221.5   1069   72 aa 
Nonsense 
mediated 
decay 
Table 1. Transcripts of human SLC6A4 gene  (Ensemble, 
GRCh38.p12). 
Protein 
SLC6A4 gene encodes a serotonin transporter 
protein (5-HTT) of 70,320 Dalton and composed of 
630 amino acids (Figure 4) (Ramamoorthy et al., 
1993). The protein belongs to family of 
neurotransmitter/sodium transporter (NSS). NSS 
family also includes dopamine, glycine and γ -
aminobutyric acid (GABA) transporters (Chen et al., 
2004). The members of this family have 12 
transmembrane domains and intracellular N and C 
terminal regions (Yamashita et al., 2005). The large 
extracellular structure (EL) between TM3 and TM4 
is modified by N-linked glycosylation in all 
eukaryotic NSS proteins and the number of N-linked 
glycosylation sites can vary from carrier to carrier. 
The consensus sequence for N-linked glycosylation 
is N-X-S/T (the amide nitrogen glycan binding 
region in the asparagine side chain and X is any 
amino acid except proline) (Mitra et al., 2006).  
The EL2 of the 5-HTT protein has two glycosylation 
sites carrying glycan (Tate and Blakely,. 1994). 
Mutations in the glycosylation sites of 5-HTT and 
other NSS proteins generally cause problems in the 
transport of neurotransmitter proteins such as 
serotonin at the cell surface (Tate  
and Blakely,.1994 ; Olivares et al., 1995; Melikian 
et al., 1996; Li et al., 2004). 
 
Figure 4. Structure of human Solute carrier family 6 
member 4.  X-ray structure of the ts3 human serotonin 
transporter complexed with paroxetine (selective serotonin 
re-uptake inhibitor) at the central site (PDB ID: 5I6X) 
(https://www.rcsb.org). 
Expression 
SLC6A4 gene is most commonly expressed in 
gastrointestinal tract, female tissues, and lung. It is 
less expressed in muscle, skin, endocrine, male, and 
female tissues (http://www.proteinatlas.org). 
Localisation 
SLC6A4 is found in various cellular compartments 
such as cytosol, endosome, plasma membrane, and 
integral component of plasma membrane, integral 
component of postsynaptic membrane, integral 
component of presynaptic membrane, 
endomembrane system, neuron projection, and 
serotonergic synapse (Müller et al., 2006; Brenner et 
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al., 2007; Ahmed  et al., 2008; Ahmed et al., 2009; 
Gaudet et al., 2011). 
Function 
5-HTT protein activity relies on the concentrations 
of intracellular potassium and extracellular sodium 
and chloride ions. It also depends on the membrane 
potential generated by sodium-potassium adenosine 
triphosphatase for the activity of the 5-HTT protein. 
The 5-HTT protein binds itself to sodium, serotonin 
and chloride ions, respectively. 
 
Figure 5. Expression profile of SLC6A4 in different 
tissues/organs in human.  Data were taken from The Human 
Protein Atlas (http://www.proteinatlas.org) in December, 
2018. 
Thus, the membrane potential mediates the release 
of sodium and chloride molecules pre-bound to the 
5-HTT protein and the 5-HTT protein passes into the 
cell. The 5-HTT protein releases serotonin in the cell 
and binds a potassium ion to itself. 5-HTT is 
activated by potassium ion and may be out of the 
cell. Serotonin (5-hydroxytryptamine; 5-HT) is an 
important neurotransmitter substance in the central 
and peripheral nervous system. After release of 5-HT 
into brain synapses, the Na+ and CI-ions-dependent 
high-affinity serotonin transporter SLC6A4 (also 
called 5-hydroxytryptamine transporter, 5-HTT, 
SERT), which is localized in presynaptic neuronal 
membranes, effectively clears 5-HT from the 
synaptic space. Thus, the synaptic activity of 5-HT 
is terminated by 5-HTT and reintroduced into the 
neurotransmitter pool for re-use. In this way, 5-HTT 
has an important role in the retrieval of serotonin and 
the execution of serotonergic function (Gelernter J. 
Et al., 1998, Catalano M., 1999).  
The 5-HTT activity is rapidly regulated by a number 
of G-protein-linked receptors and protein kinase-
associated pathways including protein kinase C 
(PKC), PRKG1 (protein kinase G, PKG), and p38 
mitogen-activated protein kinase (MAPK). The 
PKC-dependent phosphorylation and down-
regulation of the 5-HTT protein is sensitive to 
extracellular 5-HT and plays a regulatory role in the 
transport of 5-HT (Ramamoorthy et al., 1998; 
Ramamoorthy et al., 1999; Zhu et al., 2004; Samuvel 
et al., 2005; Prasad et al., 2005). 
Mutations 
Most frequent mutations are located in the 5-
HTTLPR of the promoter region of SLC6A4 gene. 
These mutations lead to the clinical picture of 
Autism (rs6365, rs28914832, rs140700) (Sutcliffe et 
al., 2005 ; Landaas et al., 2010 ; Adamsen et al., 
2011), Increased rigid-compulsive behaviour in 
autism (rs28914833, rs28914834) (Sutcliffe et al., 
2005; Rao et al., 2017), Obsessive-compulsive 
disorder (rs25532) (Wendland et al., 2007), Major 
depressive disorder (rs6354) (Rao et al., 2017), Panic 
disorder (rs3813034) (Gyawali et al., 2010), 
Unipolar disorder (Ogilvie et al., 1996), and 
Pulmonary arterial hypertension (Eddahibi et al., 
2003) (Table 2). 
Implicated in 
The serotonin carrier protein encoded by SLC6A4 
gene is the target of serotonin selective reuptake 
inhibitors, an important class of antidepressant drugs 
(Ramoz et al., 2006). Three alleles of 17-bp VNTR 
(variable number tandem repeat) were detected in 
the intron 2 region of the gene, between 9 (Stin2.9), 
10 (Stin2.10), and 12 (Stin2.12) copies. Presence of 
Stin2.9 allele in humans has been reported to 
increase the risk of Major depressive disorder 
(MDD) (Ogilvie et al., 1996). 
The 5-HTTLPR promoter sequence of the gene 
comprises two variant repeat length polymorphisms, 
known as the 16-element long (L) and 44-bp short 
(S) variant with 14 repetitive elements (Esterling et 
al., 1998; Sen et al., 2004). The L/L genotype from 
the 5-HTTLPR promoter variants causes more 5-
HTT protein expression than the L/S or S/S variants 
(Canli and Lesch, 2007).  
Analysis of lymphoblastoid cell lines with different 
genotypes revealed that the basal activity of the L 
variant of the SLC6A4 gene promoter was two times 
greater than that of the S variant (Lesch et al., 1996). 
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Figure 6. Serotonergic Synapse Pathway Map.  Once released from presynaptic axonal terminals, 5-HT binds to receptors, 
which have been divided into 7 subfamilies on the basis of conserved structures and signalling mechanisms. These families 
include the ionotropic 5-HT3 receptors and G-protein-coupled 5-HT receptors, the 5-HT1 (Gi /Go -coupled), 5-HT2 (Gq-coupled), 
5-HT4/6/7 (Gs-coupled) and 5-HT5 receptors. Presynaptically localized 5-HT1B receptors are thought to be the autoreceptors 
that suppress excess 5-HT release. 5-HT's actions are terminated by transporter- mediated reuptake into neurons, leading to 
catabolism by monoamine oxidase. Data were taken from KEGG: Kyoto Encyclopedia of Genes and Genomes 
(https://www.genome.jp/kegg/) in February, 2019. 
 
Figure 7. Pairwise alignment of SLC6A4 gene protein sequences (in distance from human) (HomoloGene, NCBI). 
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Missense/Nonsense Mutations 
# Location Mutation Protein Reported Phenotype Reference 
1 Exon 2 c.10A>G p.T4A Enhanced 5-HT transport activity 
Parasad et al., 
2005 
2 Exon2 c.167G>C p.G56A Autism, association with 
Sutcliffe et al., 
2005 
Camarena et al., 
2012 
3 chr17:30218213   c.603G>C p.K201N Increased transporter activity 
Rasmussen et al., 
2009 
4 Exon 4 c.643G>A p.E215K MAPK nonresponsiveness 
Parasad et al., 
2005 
5 Exon 6 c.878C>T p.S293F Enhanced 5-HT transport activity 
Parasad et al., 
2005 
6 Exon 7 c.1016C>T p.P339L Reduced uptake activity 
Parasad et al., 
2005 
7 Exon 8 c.1084C>A p.L362M Enhanced 5-HT transport activity 
Parasad et al.i 
2005 
8 Exon 9 c.1273A>C p.I425L Autism, association with 
Sutcliffe et al., 
2005 
9 Exon 9 c.1273A>G p.I425V 
Obsessive-compulsive 
disorder,susceptibility, association 
Ozaki et al., 
2003 
Moya et al., 
2013 
10 Exon 10 c.1393T>C p.F465L 
Increased rigid-compulsive behavior in 
autism, association with   
Sutcliffe et al., 
2005 
11 Exon 12 c.1648C>G p.L550V 
Increased rigid-compulsive behavior in 
autism, association with 
Sutcliffe et al., 
2005 
Rao et al., 2017 
12 Exon13 c.1815A>C p.K605N MAPK nonresponsiveness 
Parasad et al., 
2005 
Rao et al., 2017 
13 Exon 14 c.1861C>T p.P621S MAPK nonresponsiveness 
Parasad et al., 
2005 
Splicing Mutation 
14 chr17:30216371 c.838-155G>A NA Autism, association with 
Sutcliffe et al., 
2005 
Landaas et al., 
2010 
Regulatory Mutation 
15 chr17:30237328 c.-1936G>A NA 
Obsessive-compulsive disorder, 
association with 
Hu et al., 2006 
Perroud et al., 
2010 
Hung et al., 2011 
Moya et al., 
2013 
Stacey et al., 
2013 
16 chr17:30237152 c.-1760T>C NA 
Obsessive-compulsive disorder, 
association with 
Wendland et al., 
2008 
Fuxman Bass et 
al., 2015 
17 chr17:30222880 c.-185A>C NA 
Major depressive disorder, association 
with 
Rao et al., 2017 
18 chr17:30197993 c.463T>G NA Increased expression 
Vallender et al., 
2008 
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Seneviratne et 
al., 2009 
19 chr17:30197786 c.670T>G Na Panic disorder, association with 
Gyawali et al., 
2010 
Aoki et al., 2010 
Hartley et al., 
2012 
Deletion 
20 Promoter c.1212-1255 del TGCAGCC NA Anxiety related traits, association with 
Helis et al., 1996 
Marziniak et al., 
2005 
Borroni et al., 
2006 
Albani et al., 
2009 
  Location Repetition Sequence 
Number Of 
Repetitions   
Reported Disease/Phenotype Referance 
21 Intron 2 (GGCTGYGACCYRGRRTG)n   10-12 Unipolar disorder, association with 
Ogilvie et al., 
1996 
   
22 Intron 2 (GGCTGYGACCYRGRRTG)n 12 
Pulmonary arterial hypertension, 
association with 
Allen et al., 
2008:  
   
Cao et al., 2009    
Table 2. Solute Carrier Family 6 Member 4 (SLC6A4) related mutations.  
 
In a later study, the expression of the native SLC6A4 
gene in cultured lymphoblast cell lines from subjects 
with different SLC6A4 promoter genotypes was 
examined (Lesch et al., 1996).The mRNA 
concentration of the SLC6A4 gene in L/L cells was 
found to be 1.4 to 1.7-fold higher than the L/S and 
S/S cells (Lesch et al., 1996). Bradley et al. (2005) 
directly measured serotonin transporter mRNA 
levels and also identified 4 loci containing the 
serotonin transporter gene from 85 independent 
lymphoblast lines. They found strong impact of 5-
HTTLPR on the mRNA exression (Bradley et al., 
2005).  
The Gly56Ala substitution in the exon 2 of the 
SLC6A4 gene has been reported to be associated 
with autism and exhibit structurally high SERT 
activity (Sutcliffe et al., 2005). I425V substitution in 
the exon 9 of the SLC6A4 gene has been reported to 
be associated with obsessive-compulsive disorder 
(OCD) (Ozaki et al., 2003; Kilic et al., 2003; Zhang 
et al., 2007). In addition, A-1438G and T102C 
polymorphisms were reported to be associated with 
OCD (Taylor, 2013; Taylor, 2016). Rao et al. (2017) 
reported that I550V (exon 12) and K605N (exon 13) 
substitutions of the SLC6A4 gene are associated 
with major depression disorder (MDD) and SA (non-
fatal suicidal behavior) in addition to autism and 
OCD in 36 Chinese patients.  
Animal Experiments 
When 5-HTT was temporarily inhibited by 
fluoxetine (selective serotonin re-uptake inhibitor) in 
the early developmental period of mice, it was 
observed that adult mice exhibited abnormal 
emotional behaviors. It has been reported that 
serotonin plays a critical role in the maturation of 
brain systems that regulate emotional function, and 
that the low expression level of the SLC6A4 gene 
may be related to the development of psychiatric 
disorders in adults (Ansorge et al., 2004). A study of 
transgenic mice overexpressing the SLC6A4 gene 
and wild-type mice showed that right ventricular 
pressure was 3-fold higher in transgenic mice 
(Maclean et al., 2004). Page et al. (2009) reported 
macrocephaly in Pten +/- mice. Female Pten +/- mice 
had socialization disorder, whereas male Pten +/- 
mice had no socialization disorder. This phenotype 
was exacerbated in mice with Pten and SLC6A4 
double haploinsufficiency. As a result of these 
findings PTEN and SLC6A4 genes have been 
reported to be associated with autism spectrum 
disorder (ASD). 
Breast cancer 
High expression is found in breast cancer, but the 
gene product is not prognostic according to The 
Human Protein Atlas.  
A fusion gene PIP4K2B /SLC6A4 was found in 
breast cancer (Yoshida et al., 2013). 
SLC6A4 (solute carrier family 6 member 4) Gurbanov R, Kalkanci B 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2020; 24(1) 45 
 
Obsessive-Compulsive Disorder 
(OCD) 
Hu et al. (2006) found that the gain-of-function 
homozygous L(A)L(A) genotype was 2-fold in 
patients with OCD compared to healthy individuals. 
In a replication study in 175 trios consisting of 
probands with OCD and their parents, the L(A) allele 
was 2-fold overtransmitted to the patients with OCD. 
The HTTLPR L(A)L(A) genotype exerted 1.8-fold 
effect on risk of OCD, thus establishing the role of 
the HTT gene in OCD. In another study, the 
frequency of Stin2.12 allele in Asian patients with 
anxiety disorder (including OCD) was reported to be 
significantly higher compared to the healthy 
individuals (Ohara et al., 1998). There is also a 
possible association between OCD and Stin2.12 
allele in Spanish Caucasian population (Baca-Garcia 
et al., 2007; Saiz et al., 2008). 
Anxiety-Related Personality Traits 
The homozygous or heterozygous form of the S-
variant of the 5-HTTLPR polymorphism in the 
SLC6A4 gene has been reported to be associated 
with lower expression and openness, and higher 
neuroticism (Lesch et al., 1996). Individuals with 1-
2 copies of the S-variant of the 5-HTTLPR 
polymorphism, which is implicated in reduced 5-
HTT expression and function and increased fear and 
anxiety-related behaviours, demonstrated higher 
amygdala activity in response to fearful stimuli 
compared with individuals homozygous for the L-
variant (Hariri et al., 2002). The altered function of 
the serotonin neurotransmission system causes 
aggressive behaviour in Alzheimer's patients (AD) 
(Brown et al., 1982; Palmer et al., 1988). In a study 
conducted on 137 AD patients, the aggressive 
behaviours (58 patients) were associated with L/L 
genotype (Sukonick et al., 2001). 
Major Depressive Disorder (MDD) 
People with L/S or S/S allele in stressful life 
conditions have been reported to have more 
depression and suicidal tendency than those with L/L 
allele (Caspi et al., 2003). They also reported that the 
individual's response to environmental insults was 
determined by environmental-gene interaction 
(Caspi et al., 2003). In a study conducted on 
Pomerania population, the relationship of S-variant 
with environmental interaction and depression was 
determined. The results of the study supported 
previous studies on the gene-environment 
interaction of the S allele. It has also been revealed 
to cause high mental vulnerability to social stress and 
chronic diseases (Grabe et al., 2005). Homozygous 
or heterozygous genotypes of the S-variant were 
associated with stress-related depression and anxiety 
disorders in elite athletes (Petito et al., 2016). The 5-
HTTLPR polymorphisms of the SLC6A4 gene have 
been reported to be associated with prenatal and 
postnatal depression (Sanjuan et al., 2008; 
Oberlander et al., 2013). Interestingly, the genetic 
and epigenetic variations have been reported in the 
SLC6A4 gene of children exposed to prenatal 
depression (Devlin et al., 2010; Oppenheimer et al., 
2013; Wankerl et al., 2014; Babineau et al., 2014; 
Green et al., 2017). 5-HTTLPR polymorphisms and 
DNA methylations of SLC6A4 gene have been 
reported to be associated with depression (Devlin et 
al., 2010; Sugawara et al., 2013). 
Seasonal Affective Disorder (SAD) 
Willeit et al. (2003) genotyped 284 subjects (138 
SAD patients and 146 healthy individuals) to 
examine the relationship between L and S-variants 
in the 5-HTTLPR polymorphism of SLC6A4 gene 
with SAD. The distribution of genotype and S allele 
frequency was found similar between patients and 
healthy subjects, while they were correlated with the 
subtypes of DSM-IV depression. L allele was 
correlated with melancholic depression whereas S 
allele was related to atypical depression. It was 
concluded that 5-HTTLPR polymorphism affects the 
phenotypic disease expression but it is not the cause 
of disease.  
The effects of light therapy on serotonin transporter 
binding (5-HTT BPND), which is biomarker of 5-
HTT levels, in the anterior cingulate and prefrontal 
cortices (ACC and PFC) of healthy individuals 
during the fall and winter was studied. In winter, 
light therapy significantly decreased 5-HTT BPND by 
12% in the ACC with respect to placebo, whereas in 
the fall, no significant change in 5-HTT BPND was 
measured. In this context, it has been reported that 5-
HTT BPND can be used as a biomarker for the 
assessment of the modification effects of light 
therapy (Harrison et al., 2015). In a study on 20 SAD 
patients and 20 healthy participants the impact of 
seasonal (winter and summer) variations on 5-HTT 
activity was investigated by analysing brain 5-HTT 
BPND levels. The study reported a significant 
increase in 5-HTT BPND in different brain regions 
(including ACC and PFC) especially in severe SAD 
during winter. The 5-HTT BPND as biomarker in the 
diagnosis of SAD is important as it can be applied 
for the development of prevention strategies against 
disease progress (Tyrer et al., 2016). 
Alcoholism 
A meta-analysis study (data from 3,489 alcoholics 
and 2,325 controls) was conducted on the association 
of 5-HTTLPR polymorphisms of SLC6A4 with 
alcohol dependence. It has been reported that alcohol 
dependence complicated by a comorbid psychiatric 
condition or a more severe form of alcoholism is 
associated with the S-variant (Feinn et al., 2005). In 
a study conducted on university students, the S-
variant was reported to be associated with high 
alcohol consumption (Herman et al., 2003). High 
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alcohol consumption in men with homozygous or 
heterozygote genotypes of the S-variant has been 
reported, whereas it was seen only in the 
heterozygous women (Munaf et al., 2005). In a study 
conducted on 273 (78.5% male) alcoholic 
individuals of the Caucasus and Hispanic origin, it 
was reported that G allele carriers for the rs1042173 
SNP in the 3'UTR region of the SLC6A4 gene had 
lower alcohol consumption than T-allele 
homozygotes (Seneviratne et al., 2009). G allele 
transfection to HeLa cells resulted in higher mRNA 
and protein expression compared to T allele 
transfected cells (Seneviratne et al., 2009). 
Sudden Infant Death Syndrome 
(SIDS) 
L/L genotype and excess of L-variant have been 
reported to be associated with SIDS (Narita et al., 
2001; Weese-Mayer et al., 2003). In addition, the 
Stin2.12 allele has been associated with SIDS in 
African-Americans and Japanese, whereas it is not 
associated with SIDS in Caucasian-Americans 
(Narita et al., 2001; Weese-Mayer et al., 2003). 
Panic Disorder (PD) 
The rs3813034 variant in the 3'UTR region of the 
SLC6A4 gene has been reported to be related to PD 
(Gyawali et al., 2010). Decreased SLC6A4 gene 
expression due to the gene polymorphisms in 
midbrain, hypothalamus and temporal lobe has been 
associated with PD (Maron et al., 2006). Strug et al. 
(2010) reported that rs140701 variant of the 
SLC6A4 gene may be associated with PD. 
Bipolar Affective Disorder (BPAD) or 
Manic-Depressive Illness (MDI) 
The disorder of the neurotransmitter system, 
including serotonin and monoamines, has been 
reported to be associated with bipolar disorder (Scott 
et al., 1979; Kapur and Remington, 1992). The 
patients with BPAD without panic disorder exhibited 
statistically higher frequencies of the Catechol O-
Methyltransferase (COMT) Met158 and the S-
variant 5-HTTLPR genotypes with respect to healthy 
individuals (Rotondo et al., 2002). When the 
relationship between L and S-variant 
polymorphisms of SLC6A4 gene and BPAD and 
unipolar depression were investigated by meta-
analysis study, it was revealed that the S-variant 
could be associated with BPAD but not with unipolar 
depression. The L-variant was not implicated in 
BPAD and/or unipolar depression (Lasky-Su et al., 
2005). However other studies reported no significant 
relationship between SLC6A4 5-HTTLPR and 
VNTR polymorphisms and BPAD (Mendlewicz et 
al., 2004; Cho et al., 2005). The association between 
epigenetic variations of SLC6A4 gene and BPAD 
were studied on 20 bipolar monozygotic twins with 
respect to 20 healthy subjects. The promoter-wide 
DNA methylation analysis of lymphoblastic cell 
lines (LCLs) revealed DNA hypermethylation in 
SLC6A4 gene that can be an epigenetic mark 
resulting from a G×E interaction leading to the 
development of BPED (Sugawara et al., 2011). In a 
study on the association of SLC6A4 and DRD2 
(dopamine D2 receptor) genes with BPED, the 
gender specific differences in SLC6A4 gene 
polymorphisms were reported. The results revealed 
gender-specific association of the DRD2 A1/A1 and 
the 5-HTTLPR S/S, S/LG, and LG/LG (S+) 
genotypes in type I and type II men, but not in 
women. A significant interaction for the DRD2 
A1/A1 and 5-HTTLPR S+ polymorphisms was also 
found only in type I and type II men (Wang et al., 
2014). 
Pulmonary Hypertension (PPH) 
Smooth muscle cells (SMC) of pulmonary artery in 
PPH patients grow faster than controls when 5-HTT 
expression is stimulated by serotonin. As a result of 
these findings, 5-HTT has been shown to play a key 
role in the pathogenesis of SMC proliferation and 5-
HTT polymorphisms are associated with PHH 
(Eddahibi et al., 2001). The higher 5-HTT 
expression was reported in pulmonary artery SMC in 
patients with L/L genotypes compared to L/S and 
S/S genotypes, resulting in more severe PPH. 
(Eddahibi et al., 2003). In a study on the association 
of idiopathic PPH with 5-HTT polymorphism in 
children, the L/L genotype has been reported to be 
associated with the aetiology of PPH (Vachharajani 
and Saunders, 2005). 
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